Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.
Butterfly Network Inc (NYSE: BFLY) pioneers accessible medical imaging solutions through its revolutionary Ultrasound-on-Chip™ technology. This dedicated news hub provides investors and healthcare professionals with essential updates on product innovations, financial developments, and strategic initiatives driving the future of point-of-care diagnostics.
Discover official press releases covering earnings announcements, regulatory milestones, and partnerships advancing AI-powered ultrasound technology. Our curated collection ensures timely access to verified information about BFLY's handheld imaging systems, educational programs, and market expansion efforts.
Key updates include product launch details, clinical validation studies, and executive leadership changes. Bookmark this page to monitor how Butterfly Network's cloud-connected devices and ScanLab™ training tools continue transforming medical imaging accessibility worldwide.
Butterfly Network, Inc. (NYSE: BFLY) announced it will report its first quarter 2023 financial results and provide a business update on May 11, 2023, prior to the market opening. The event will be followed by a conference call at 8:30 am ET, featuring key executives including CEO Joseph DeVivo and CFO Heather Getz. The call will be accessible via webcast on the company’s Investor Relations website and can also be joined by phone.
Butterfly, known for its revolutionary handheld ultrasound technology, aims to democratize medical imaging. The company’s focus on making ultrasound accessible globally aligns with its mission to enhance health equity. The innovative Butterfly iQ+ ultrasound device is now available to qualified healthcare practitioners across various regions worldwide.
Butterfly Network has appointed Joseph M. DeVivo as its new President and CEO, taking effect immediately. DeVivo brings over 35 years of experience in healthcare leadership, including a notable record at InTouch Health, where he achieved a 30% annual revenue growth and facilitated a $1.1 billion sale to Teladoc Health. He has also held significant positions at AngioDynamics and Smith and Nephew. DeVivo aims to enhance the accessibility of Butterfly's iQ+ ultrasound technology, making it as ubiquitous as the stethoscope. His appointment aligns with the company’s recent 510(k) clearance for an AI-enabled Auto B-line Counter, expected to launch in Summer 2023, which could revolutionize diagnostics in lung function evaluations.
Butterfly Network has announced the 510(k) clearance for its groundbreaking AI-enabled Auto B-line Counter, enhancing lung condition assessments. Utilizing deep learning technology, this new tool simplifies the evaluation of abnormal lung conditions by counting B-lines from a quick ultrasound clip, significantly speeding up diagnosis and treatment. The algorithm is trained on a dataset of over 3.5 million de-identified ultrasound images sourced from across the U.S. The company aims to launch this innovative solution in early summer 2023, aiming to improve healthcare accessibility and democratize medical imaging.
FAQ
What is the current stock price of Butterfly Network (BFLY)?
What is the market cap of Butterfly Network (BFLY)?
